Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial.
Kataoka K, Nishiyama O, Ogura T, Mori Y, Kozu R, Arizono S, Tsuda T, Tomioka H, Tomii K, Sakamoto K, Ishimoto H, Kagajo M, Ito H, Ichikado K, Sasano H, Eda S, Arita M, Goto Y, Hataji O, Fuke S, Shintani R, Hasegawa H, Ando M, Ogawa T, Shiraishi M, Watanabe F, Nishimura K, Sasaki T, Miyazaki S, Saka H, Kondoh Y; FITNESS study Collaborators. Kataoka K, et al. Among authors: tsuda t. Thorax. 2023 Aug;78(8):784-791. doi: 10.1136/thorax-2022-219792. Epub 2023 Apr 3. Thorax. 2023. PMID: 37012071 Clinical Trial.
Stratifying the risk of COPD exacerbation using the modified Medical Research Council scale: a multicenter cross-sectional CAP study.
Matsunaga K, Hayata A, Akamatsu K, Hirano T, Tamada T, Kamei T, Tsuda T, Nakamura H, Takahashi T, Hozawa S, Mori Y, Sakamoto Y, Kimura K, Katsumata U, Miura M, Ichinose M. Matsunaga K, et al. Among authors: tsuda t. Respir Investig. 2015 Mar;53(2):82-5. doi: 10.1016/j.resinv.2014.10.006. Epub 2014 Nov 18. Respir Investig. 2015. PMID: 25745853 No abstract available.
Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial.
Machida K, Kawayama T, Kinoshita M, Ichinose M, Tsuda T, Takata S, Koto H, Yoshida M, Ashihara Y, Kawashima M, Suna H, Inoue H. Machida K, et al. Among authors: tsuda t. Int J Chron Obstruct Pulmon Dis. 2019 Sep 19;14:2175-2184. doi: 10.2147/COPD.S223002. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31571853 Free PMC article. Clinical Trial.
Development of the Japanese version of the COPD Assessment Test.
Tsuda T, Suematsu R, Kamohara K, Kurose M, Arakawa I, Tomioka R, Kawayama T, Hoshino T, Aizawa H. Tsuda T, et al. Respir Investig. 2012 Jun;50(2):34-9. doi: 10.1016/j.resinv.2012.05.003. Epub 2012 Jun 19. Respir Investig. 2012. PMID: 22749248
A Novel Risk Score for Major Bleeding in Japanese Patients with Non-Valvular Atrial Fibrillation: The J-RISK AF Study.
Akao M, Tomita H, Nakai M, Kodani E, Suzuki S, Hayashi K, Sawano M, Goya M, Yamashita T, Fukuda K, Tsuda T, Isobe M, Toyoda K, Miyamoto Y, Okamura T, Sasahara Y, Okumura K; J-RISK AF Research Group. Akao M, et al. Among authors: tsuda t. J Atheroscler Thromb. 2024 May 28. doi: 10.5551/jat.64842. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 38811233 Free article.
1,628 results